FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014784604> ?p ?o ?g. }

• W2014784604 endingPage "2198" @default.
• W2014784604 startingPage "2182" @default.
• W2014784604 abstract "Brief ischemic episodes confer marked protection against myocardial stunning 1-3 d later (late preconditioning [PC] against stunning). The mechanism of this powerful protective effect is poorly understood. Although protein kinase C (PKC) has been implicated in PC against infarction, it is unknown whether it triggers late PC against stunning. In addition, the entire PKC hypothesis of ischemic PC remains controversial, possibly because the effects of PKC inhibitors on PC protection have not been correlated with their effects on PKC activity and/or translocation in vivo. Thus, conscious rabbits underwent a sequence of six 4-min coronary occlusion (O)/4-min reperfusion (R) cycles for three consecutive days (days 1, 2, and 3). In the control group (group I, n = 7), the recovery of systolic wall thickening after the six O/R cycles was markedly improved on days 2 and 3 compared with day 1, indicating the development of late PC against stunning. Administration of the PKC inhibitor chelerythrine at a dose of 5 mg/kg before the first O on day 1 (group II, n = 10) abrogated the late PC effect against stunning, whereas a 10-fold lower dose (0.5 mg/kg; group III, n = 7) did not. Administration of 5 mg/kg of chelerythrine 10 min after the sixth reperfusion on day 1 (group IV, n = 6) failed to block late PC against stunning. When rabbits were given 5 mg/kg of chelerythrine in the absence of O/R (group V, n = 5), the severity of myocardial stunning 24 h later was not modified. Pretreatment with phorbol 12-myristate 13-acetate (4 microg/kg) on day 1 without ischemia (group VI, n = 11) induced late PC against stunning on day 2 and the magnitude of this effect was equivalent to that observed after ischemic PC. In vehicle-treated rabbits (group VIII, n = 5), the six O/R cycles caused translocation of PKC isoforms epsilon and eta from the cytosolic to the particulate fraction without significant changes in total PKC activity, in the subcellular distribution of total PKC activity, or in the subcellular distribution of the alpha, beta1, beta2, gamma, delta, zeta, iota, lambda, and mu isoforms. The higher dose of chelerythrine (5 mg/kg; group X, n = 5) prevented the translocation of both PKC epsilon and eta induced by ischemic PC, whereas the lower dose (0.5 mg/kg; group XI, n = 5) prevented the translocation of PKC eta but not that of epsilon, indicating that the activation of epsilon is necessary for late PC to occur whereas that of eta is not. To our knowledge, this is the first demonstration that a PKC inhibitor actually prevents the translocation of PKC induced by ischemic PC in vivo, and that this inhibition of PKC translocation results in loss of PC protection. Taken together, the results demonstrate that the mechanism of late PC against myocardial stunning in conscious rabbits involves a PKC-mediated signaling pathway, and implicate epsilon as the specific PKC isoform responsible for the development of this cardioprotective phenomenon." @default.
• W2014784604 created "2016-06-24" @default.
• W2014784604 creator A5000397083 @default.
• W2014784604 creator A5006098122 @default.
• W2014784604 creator A5008671980 @default.
• W2014784604 creator A5008776901 @default.
• W2014784604 creator A5011970404 @default.
• W2014784604 creator A5019873352 @default.
• W2014784604 creator A5029768980 @default.
• W2014784604 creator A5058527965 @default.
• W2014784604 creator A5071672663 @default.
• W2014784604 creator A5076668116 @default.
• W2014784604 date "1998-05-15" @default.
• W2014784604 modified "2023-10-12" @default.
• W2014784604 title "Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that epsilon is the isoform involved." @default.
• W2014784604 cites W1528325393 @default.
• W2014784604 cites W189079880 @default.
• W2014784604 cites W1964436832 @default.
• W2014784604 cites W1964646716 @default.
• W2014784604 cites W1967526945 @default.
• W2014784604 cites W1970722184 @default.
• W2014784604 cites W1974388096 @default.
• W2014784604 cites W1978221784 @default.
• W2014784604 cites W1981527120 @default.
• W2014784604 cites W1983537876 @default.
• W2014784604 cites W1986905765 @default.
• W2014784604 cites W1999718670 @default.
• W2014784604 cites W2007330950 @default.
• W2014784604 cites W2019975211 @default.
• W2014784604 cites W2021612538 @default.
• W2014784604 cites W2028855217 @default.
• W2014784604 cites W2040382523 @default.
• W2014784604 cites W2041489592 @default.
• W2014784604 cites W2041986157 @default.
• W2014784604 cites W2044547504 @default.
• W2014784604 cites W2052489622 @default.
• W2014784604 cites W2059578202 @default.
• W2014784604 cites W2060120053 @default.
• W2014784604 cites W2068442498 @default.
• W2014784604 cites W2072923057 @default.
• W2014784604 cites W2074219189 @default.
• W2014784604 cites W2083708483 @default.
• W2014784604 cites W2085547973 @default.
• W2014784604 cites W2089475281 @default.
• W2014784604 cites W2089514906 @default.
• W2014784604 cites W2094842975 @default.
• W2014784604 cites W2095566192 @default.
• W2014784604 cites W2095621789 @default.
• W2014784604 cites W2096986919 @default.
• W2014784604 cites W2118056513 @default.
• W2014784604 cites W2126241200 @default.
• W2014784604 cites W2127025604 @default.
• W2014784604 cites W2127541214 @default.
• W2014784604 cites W2129167542 @default.
• W2014784604 cites W2132494613 @default.
• W2014784604 cites W2139834613 @default.
• W2014784604 cites W2157284266 @default.
• W2014784604 cites W2160696128 @default.
• W2014784604 cites W2161074774 @default.
• W2014784604 cites W2164183838 @default.
• W2014784604 cites W2210726304 @default.
• W2014784604 cites W2408352480 @default.
• W2014784604 doi "https://doi.org/10.1172/jci1258" @default.
• W2014784604 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/508806" @default.
• W2014784604 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9593774" @default.
• W2014784604 hasPublicationYear "1998" @default.
• W2014784604 type Work @default.
• W2014784604 sameAs 2014784604 @default.
• W2014784604 citedByCount "158" @default.
• W2014784604 countsByYear W20147846042012 @default.
• W2014784604 countsByYear W20147846042013 @default.
• W2014784604 countsByYear W20147846042015 @default.
• W2014784604 countsByYear W20147846042017 @default.
• W2014784604 countsByYear W20147846042019 @default.
• W2014784604 countsByYear W20147846042020 @default.
• W2014784604 countsByYear W20147846042021 @default.
• W2014784604 countsByYear W20147846042023 @default.
• W2014784604 crossrefType "journal-article" @default.
• W2014784604 hasAuthorship W2014784604A5000397083 @default.
• W2014784604 hasAuthorship W2014784604A5006098122 @default.
• W2014784604 hasAuthorship W2014784604A5008671980 @default.
• W2014784604 hasAuthorship W2014784604A5008776901 @default.
• W2014784604 hasAuthorship W2014784604A5011970404 @default.
• W2014784604 hasAuthorship W2014784604A5019873352 @default.
• W2014784604 hasAuthorship W2014784604A5029768980 @default.
• W2014784604 hasAuthorship W2014784604A5058527965 @default.
• W2014784604 hasAuthorship W2014784604A5071672663 @default.
• W2014784604 hasAuthorship W2014784604A5076668116 @default.
• W2014784604 hasBestOaLocation W20147846041 @default.
• W2014784604 hasConcept C126322002 @default.
• W2014784604 hasConcept C134018914 @default.
• W2014784604 hasConcept C184235292 @default.
• W2014784604 hasConcept C185592680 @default.
• W2014784604 hasConcept C195794163 @default.
• W2014784604 hasConcept C2775992611 @default.
• W2014784604 hasConcept C2776108454 @default.
• W2014784604 hasConcept C2778492669 @default.
• W2014784604 hasConcept C2779311647 @default.

• next